Bloomberg Television published this video item, entitled “Novo Sees ‘Significant Step Up’ for US Wegovy Supply in 2024: CFO” – below is their description.
Novo Nordisk CFO Karsten Munk Knudsen says the US is the main driver for growth of the company’s obesity drugs as profit rose 47% in the third quarter. He speaks on “Bloomberg Brief.”
——–
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on…
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
Bloomberg Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.